Samuel D. Isaly, Director at Loxo Oncology, Inc. (LOXO), sold 496,700 shares at $72.46 ($36.9M) on 2017-11-16, disclosed to the SEC on 2017-11-20.
Open-market sale of $36.9M LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.46 | 46,680 | $3.4M | 9.2% |
| 2 | $72.46 | 46,680 | $3.4M | 9.2% |
| 3 | $73.48 | 43,300 | $3.2M | 8.6% |
| 4 | $74.49 | 100,045 | $7.5M | 20.2% |
| 5 | $74.49 | 100,045 | $7.5M | 20.2% |
| 6 | $75.37 | 71,598 |
| $5.4M |
| 14.6% |
| 7 | $75.37 | 71,598 | $5.4M | 14.6% |
| 8 | $76.23 | 8,377 | $639K | 1.7% |
| 9 | $76.23 | 8,377 | $639K | 1.7% |
| Total | $74.33 avg | 496,700 | $36.9M | 100% |
| Filing → |
| BOLD | SELL | 2017-09-29 | $19.0M | — | Filing → |
| ROKA | SELL | 2017-09-28 | $202K | — | Filing → |
| GKOS | SELL | 2017-09-05 | $22.5M | — | Filing → |